Volume 13 Issue 1
Jan.  2022
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2022  >  13(1): 88-97
Hu Shasha, Liu Yu, Wang Chaoyang, et al. Effect of HMGB1/Caspase-1/GSDMD signaling axis-mediated hepatocyte pyroptosis on liver ischemia-reperfusion injury[J]. ORGAN TRANSPLANTATION, 2022, 13(1): 88-97. doi: 10.3969/j.issn.1674-7445.2022.01.014
Citation: Hu Shasha, Liu Yu, Wang Chaoyang, et al. Effect of HMGB1/Caspase-1/GSDMD signaling axis-mediated hepatocyte pyroptosis on liver ischemia-reperfusion injury[J]. ORGAN TRANSPLANTATION, 2022, 13(1): 88-97. doi: 10.3969/j.issn.1674-7445.2022.01.014
shu

Effect of HMGB1/Caspase-1/GSDMD signaling axis-mediated hepatocyte pyroptosis on liver ischemia-reperfusion injury

doi: 10.3969/j.issn.1674-7445.2022.01.014

  • Graduate School of Tianjin Medical University, the First Central Clinical College of Tianjin Medical University, Tianjin 300070, China

More Information
  • Corresponding author: Zhang Guoliang, Email: zgl_022@126.com; Cai Jinzhen, Email: caijinzhen@sina.com
  • Received Date: 2021-08-11
    Available Online: 2022-01-12
  • Publish Date: 2022-01-15
    Abstract
  •   Objective  To evaluate the effect of high mobility group box 1 (HMGB1)/ cysteinyl aspartate specific proteinase (Caspase)-1/Gasdermin D (GSDMD) signaling axis-mediated hepatocyte pyroptosis on liver ischemia-reperfusion injury (IRI).  Methods  C57BL/6 mice were randomly divided into the sham operation group (Sham group), IRI 2 h group, IRI 6 h group, IRI 12 h group, glycyrrhizic acid (GA)+Sham group and GA+IRI 12 h group (n=8 in each group). AML12 cells were evenly divided into the Sham group, IRI 12 h group, GA+Sham group and GA+IRI 12 h group. The serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), interleukin (IL)-1β and IL-6 in each group were detected by enzyme-linked immune absorbent assay(ELISA). The messenger ribonucleic acid (mRNA) levels of IL-1β and IL-6 were detected by reverse transcription polymerase chain reaction(RT-PCR). The pathological score of liver ischemia and cell apoptosis were compared among all groups. The expression level of HMGB1 in the liver tissues of each group was determined by immunohistochemistry. The expression levels of HMGB1, Caspase-1 and GSDMD proteins in the mouse liver tissues and AML12 cells were measured by Western blot.  Results  Compared with the Sham group, the serum levels of ALT, AST, IL-1β and IL-6 and the relative expression levels of IL-1β and IL-6 mRNA in the liver tissues were all significantly up-regulated after IRI in each group (all P < 0.05), and showed significant time-dependent pattern along with the prolongation of reperfusion time. Compared with the Sham group, the pathological score of hepatic ischemia and the apoptosis rate of hepatocytes were significantly increased after IRI in each group (all P < 0.05). Immunohistochemical results showed that the expression level of HMGB1 in the liver tissues was significantly up-regulated after IRI, which showed an increasing trend along with the prolongation within the period of 2-12 h. Western blot showed that compared with the Sham group, the relative expression levels of HMGB1, Caspase-1 and GSDMD proteins in vivo and in vitro were up-regulated in the IRI 12 h group. The relative expression level of HMGB1 protein was significantly up-regulated, whereas those of Caspase-1 and GSDMD proteins were significantly down-regulated in the GA+IRI 12 h group compared with those in the IRI 12 h group (all P < 0.05).  Conclusions  Hepatocytes probably activate the Caspase-1/GSDMD signaling pathway by releasing HMGB1, thereby triggering hepatocyte pyroptosis and leading to liver IRI. Inhibition of extracellular release of HMGB1 by GA may mitigate liver IRI.

     

    • FullText(HTML)
  • loading
    • References(40)
  • [1]
    JIMÉNEZ-CASTRO MB, CORNIDE-PETRONIO ME, GRACIA-SANCHO J, et al. Inflammasome-mediated inflammation in liver ischemia-reperfusion injury[J]. Cells, 2019, 8(10): 1131. DOI: 10.3390/cells8101131.
    [2]
    潘宁波, 张旭阳, 张玉, 等. AMPK激动剂预处理对肝缺血再灌注损伤大鼠模型的影响及相关机制[J]. 临床肝胆病杂志, 2021, 37(5): 1152-1157. DOI: 10.3969/j.issn.1001-5256.2021.05.034.

    PAN NB, ZHANG XY, ZHANG Y, et al. Effect of pretreatment with adenosine monophosphate -activated protein kinase agonist on a rat model of hepatic ischemia-reperfusion injury and related mechanism[J]. J Clin Hepatol, 2021, 37(5): 1152-1157. DOI: 10.3969/j.issn.1001-5256.2021.05.034.
    [3]
    JIANG X, KUANG G, GONG X, et al. Glycyrrhetinic acid pretreatment attenuates liver ischemia/reperfusion injury via inhibiting TLR4 signaling cascade in mice[J]. Int Immunopharmacol, 2019, 76: 105870. DOI: 10.1016/j.intimp.2019.105870.
    [4]
    HU ZG, ZHOU Y, LIN CJ, et al. Emerging recognition of the complement system in hepatic ischemia/reperfusion injury, liver regeneration and recovery (review)[J]. Exp Ther Med, 2021, 21(3): 223. DOI: 10.3892/etm.2021.9654.
    [5]
    WASEEM N, CHEN PH. Hypoxic hepatitis: a review and clinical update[J]. J Clin Transl Hepatol, 2016, 4(3): 263-268. DOI: 10.14218/JCTH.2016.00022.
    [6]
    王小莹, 刘作金, 申丽娟. 缺血再灌注损伤与细胞焦亡的相关性研究进展[J]. 昆明医科大学学报, 2020, 41(12): 142-147. DOI: 10.12259/j.issn.2095-610X.S20201240.

    WANG XY, LIU ZJ, SHEN LJ. Review of correlation between ischemia-reperfusion injury and pyroptosis[J]. J Kunming Med Univ, 2020, 41(12): 142-147. DOI: 10.12259/j.issn.2095-610X.S20201240.
    [7]
    KIM SW, LEE JK. Role of HMGB1 in the interplay between NETosis and thrombosis in ischemic stroke: a review[J]. Cells, 2020, 9(8): 1794. DOI: 10.3390/cells9081794.
    [8]
    LENG Y, CHEN R, CHEN R, et al. HMGB1 mediates homocysteine-induced endothelial cells pyroptosis via cathepsin V-dependent pathway[J]. Biochem Biophys Res Commun, 2020, 532(4): 640-646. DOI: 10.1016/j.bbrc.2020.08.091.
    [9]
    吴云娇, 黄锋, 卢创宏, 等. HMGB1介导线粒体自噬参与糖尿病小鼠心肌缺血/再灌注损伤[J]. 广西医科大学学报, 2021, 38(4): 655-661. DOI: 10.16190/j.cnki.45-1211/r.2021.04.005.

    WU YJ, HUANG F, LU CH, et al. HMGB1 mediates mitochondrial autophagy and participates in myocardial ischemia/reperfusion injury in diabetic mice[J]. J Guangxi Med Univ, 2021, 38(4): 655-661. DOI: 10.16190/j.cnki.45-1211/r.2021.04.005.
    [10]
    WANG Y, GAO W, SHI X, et al. Chemotherapy drugs induce pyroptosis through Caspase-3 cleavage of a gasdermin[J]. Nature, 2017, 547(7661): 99-103. DOI: 10.1038/nature22393.
    [11]
    TSUCHIYA K. Switching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor immunity[J]. Int J Mol Sci, 2021, 22(1): 426. DOI: 10.3390/ijms22010426.
    [12]
    ZHENG X, CHEN W, GONG F, et al. The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review[J]. Front Immunol, 2021, 12: 711939. DOI: 10.3389/fimmu.2021.711939.
    [13]
    HUA S, MA M, FEI X, et al. Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated Kupffer cells pyroptosis[J]. Int Immunopharmacol, 2019, 68: 145-155. DOI: 10.1016/j.intimp.2019.01.002.
    [14]
    XIE K, CHEN YQ, CHAI YS, et al. HMGB1 suppress the expression of IL-35 by regulating Naïve CD4+ T cell differentiation and aggravating Caspase-11-dependent pyroptosis in acute lung injury[J]. Int Immunopharmacol, 2021, 91: 107295. DOI: 10.1016/j.intimp.2020.107295.
    [15]
    HOU J, HSU JM, HUNG MC. Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity[J]. Mol Cell, 2021, 81(22): 4579-4590. DOI: 10.1016/j.molcel.2021.09.003.
    [16]
    TANG D, WANG H, BILLIAR TR, et al. Emerging mechanisms of immunocoagulation in sepsis and septic shock[J]. Trends Immunol, 2021, 42(6): 508-522. DOI: 10.1016/j.it.2021.04.001.
    [17]
    WU J, SUN J, MENG X. Pyroptosis by Caspase-11 inflammasome-Gasdermin D pathway in autoimmune diseases[J]. Pharmacol Res, 2021, 165: 105408. DOI: 10.1016/j.phrs.2020.105408.
    [18]
    LI S, ZHU Z, XUE M, et al. The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice[J]. Redox Biol, 2021, 40: 101859. DOI: 10.1016/j.redox.2021.101859.
    [19]
    LI J, ZHAO J, XU M, et al. Blocking GSDMD processing in innate immune cells but not in hepatocytes protects hepatic ischemia-reperfusion injury[J]. Cell Death Dis, 2020, 11(4): 244. DOI: 10.1038/s41419-020-2437-9.
    [20]
    OGIKU M, KONO H, HARA M, et al. Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats[J]. J Pharmacol Exp Ther, 2011, 339(1): 93-98. DOI: 10.1124/jpet.111.182592.
    [21]
    NOGUCHI D, KURIYAMA N, HIBI T, et al. The impact of dabigatran treatment on sinusoidal protection against hepatic ischemia/reperfusion injury in mice[J]. Liver Transpl, 2021, 27(3): 363-384. DOI: 10.1002/lt.25929.
    [22]
    MA J, HU H, LIN M, et al. ELABELA alleviates syncytiotrophoblast hypoxia/reoxygenation injury and preeclampsia-like symptoms in mice by reducing apoptosis[J]. Placenta, 2021, 106: 30-39. DOI: 10.1016/j.placenta.2021.02.002.
    [23]
    YE L, HE S, MAO X, et al. Effect of hepatic macrophage polarization and apoptosis on liver ischemia and reperfusion injury during liver transplantation[J]. Front Immunol, 2020, 11: 1193. DOI: 10.3389/fimmu.2020.01193.
    [24]
    SHI G, ZHANG Z, MA S, et al. Hepatic interferon regulatory factor 8 expression mediates liver ischemia/reperfusion injury in mice[J]. Biochem Pharmacol, 2021, 192: 114728. DOI: 10.1016/j.bcp.2021.114728.
    [25]
    YANG Q, ZHAO ZZ, XIE J, et al. Senkyunolide I attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative, anti-inflammatory and anti-apoptotic pathways[J]. Int Immunopharmacol, 2021, 97: 107717. DOI: 10.1016/j.intimp.2021.107717.
    [26]
    XUE J, SUAREZ JS, MINAAI M, et al. HMGB1 as a therapeutic target in disease[J]. J Cell Physiol, 2021, 236(5): 3406-3419. DOI: 10.1002/jcp.30125.
    [27]
    VOONG CK, GOODRICH JA, KUGEL JF. Interactions of HMGB proteins with the genome and the impact on disease[J]. Biomolecules, 2021, 11(10): 1451. DOI: 10.3390/biom11101451.
    [28]
    XU L, GE F, HU Y, et al. Sevoflurane postconditioning attenuates hepatic ischemia-reperfusion injury by limiting HMGB1/TLR4/NF-κB pathway via modulating microRNA-142 in vivo and in vitro[J]. Front Pharmacol, 2021, 12: 646307. DOI: 10.3389/fphar.2021.646307.
    [29]
    NI YA, CHEN H, NIE H, et al. HMGB1: an overview of its roles in the pathogenesis of liver disease[J]. J Leukoc Biol, 2021, 110(5): 987-998. DOI: 10.1002/JLB.3MR0121-277R.
    [30]
    刘涛, 刘伟欣, 贺明, 等. 丹参酮Ⅱ-A磺酸钠通过调控高迁移率组蛋白1减轻内毒素导致的大鼠急性肺损伤[J]. 实用医学杂志, 2020, 36(2): 164-169. DOI: 10.3969/j.issn.1006-5725.2020.02.007.

    LIU T, LIU WX, HE M, et al. Tanshinone ⅡA sodium sulfonate attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats[J]. J Pract Med, 2020, 36(2): 164-169. DOI: 10.3969/j.issn.1006-5725.2020.02.007.
    [31]
    ZHOU Y, CHEN Z, YANG X, et al. Morin attenuates pyroptosis of nucleus pulposus cells and ameliorates intervertebral disc degeneration via inhibition of the TXNIP/NLRP3/Caspase-1/IL-1β signaling pathway[J]. Biochem Biophys Res Commun, 2021, 559: 106-112. DOI: 10.1016/j.bbrc.2021.04.090.
    [32]
    GU G, HUO Y, XU G, et al. MicroRNA-204-GSDMD interaction regulates pyroptosis of fibroblast-like synoviocytes in ankylosing spondylitis[J]. Int Immunopharmacol, 2021, 91: 107227. DOI: 10.1016/j.intimp.2020.107227.
    [33]
    FAN K, YANG J, GONG WY, et al. NLRP3 inflammasome activation mediates sleep deprivation-induced pyroptosis in mice[J]. PeerJ, 2021, 9: e11609. DOI: 10.7717/peerj.11609.
    [34]
    HUMPHRIES F, SHMUEL-GALIA L, KETELUT-CARNEIRO N, et al. Succination inactivates Gasdermin D and blocks pyroptosis[J]. Science, 2020, 369(6511): 1633-1637. DOI: 10.1126/science.abb9818.
    [35]
    YE SM, ZHOU MZ, JIANG WJ, et al. Silencing of Gasdermin D by siRNA-loaded PEI-chol lipopolymers potently relieves acute gouty arthritis through inhibiting pyroptosis[J]. Mol Pharm, 2021, 18(2): 667-678. DOI: 10.1021/acs.molpharmaceut.0c00229.
    [36]
    尹朝奇, 贺全勇, 罗成群, 等. HSF-1在HMGB1诱导的炎症反应中的作用[J]. 中国普通外科杂志, 2016, 25(9): 1291-1295. DOI: 10.3978/j.issn.1005-6947.2016.09.011.

    YIN ZQ, HE QY, LUO CQ, et al. Role of HSF-1 in inflammatory response induced by HMGB1[J]. Chin J Gen Surg, 2016, 25(9): 1291-1295. DOI: 10.3978/j.issn.1005-6947.2016.09.011.
    [37]
    SOSA RA, TERRY AQ, KALDAS FM, et al. Disulfide high-mobility group box 1 drives ischemia-reperfusion injury in human liver transplantation[J]. Hepatology, 2021, 73(3): 1158-1175. DOI: 10.1002/hep.31324.
    [38]
    ZHANG S, FENG Z, GAO W, et al. Aucubin attenuates liver ischemia-reperfusion injury by inhibiting the HMGB1/TLR-4/NF-κB signaling pathway, oxidative stress, and apoptosis[J]. Front Pharmacol, 2020, 11: 544124. DOI: 10.3389/fphar.2020.544124.
    [39]
    NAKAMURA K, KAGEYAMA S, KALDAS FM, et al. Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury[J]. J Clin Invest, 2020, 130(5): 2689-2704. DOI: 10.1172/JCI133142.
    [40]
    WANG W, WU L, LI J, et al. Alleviation of hepatic ischemia reperfusion injury by oleanolic acid pretreating via reducing HMGB1 release and inhibiting apoptosis and autophagy[J]. Mediators Inflamm, 2019: 3240713. DOI: 10.1155/2019/3240713.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(7)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (865) PDF downloads(211) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return